TP53mutation predicts for poor overall survival in DLBCL. (A) Overall survival of patients with TP53 mutations versus those with WT TP53. (B) Overall survival of patients with TP53 deletions versus those with WT TP53. (C) Overall survival of patients with TP53 alterations (combined mutations, deletions, or both) versus those with WT TP53. (D) Overall survival of mutant and WT TP53 patients within the ABC subtype of DLBCL. (E) Overall survival of patients with mutant and WT TP53 within the GCB subtype.